Net selling: insiders sold $6.1M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys/Adds (2)
Point72
$128.5M
added
AQR
$79.4M
added
Sells/Trims (1)
Terry Smith
$717.0M
sold
No tracked top-trader positions in MTD as of Oct 24, 09:18 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Jul 30, 2026
Financial period
Q2 2026
Earnings per share
$10.80 expected
Revenue
Company release
Estimates as of Oct 24, 2026
EPS expected
$11.82 to $12.28
Revenue expected
11 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 30, 2026 | $11.46 / $10.80Yahoo Finance | +6.09% beat | $1.03B No estimate | Unavailable |
| Mar 31, 2026 | May 7, 2026 | $8.91 / $8.71Yahoo Finance | +2.33% beat | $947.1M No estimate | Unavailable |
| Dec 31, 2025 | Feb 5, 2026 | $13.36 / $12.81Yahoo Finance | +4.31% beat | $1.13B No estimate | Unavailable |
| Sep 30, 2025 | Nov 6, 2025 | $11.15 / $10.66Yahoo Finance | +4.64% beat | $1.03B No estimate | Unavailable |
| Jun 30, 2025 | Jul 31, 2025 | $10.09 / $9.60Alpha Vantage | +5.10% beat | $983.2M No estimate | Unavailable |
| Mar 31, 2025 | May 1, 2025 | $8.19 / $7.88Alpha Vantage | +3.93% beat | $883.7M No estimate | Unavailable |
| Dec 31, 2024 | Feb 6, 2025 | $12.41 / $11.72Alpha Vantage | +5.89% beat | $1.05B No estimate | Unavailable |
| Sep 30, 2024 | Nov 8, 2024 | $10.21 / $10.01Alpha Vantage | +2.00% beat | $954.5M No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.03B | $1.13B | $947.1M | $1.03B |
| Cost of what it sold | $440.3M | $474.0M | $410.9M | $396.5M |
| Gross profit | $589.4M | $655.8M | $536.2M | $630.8M |
| What it spent | ||||
| Research and development | $51.1M | $52.6M | $51.3M | $53.0M |
| Sales and admin | $248.4M | $259.8M | $258.3M | $263.3M |
| Total operating expenses | $299.5M | $312.4M | $309.6M | $316.3M |
| What was left | ||||
| Operating profit | $289.9M | $343.3M | $226.6M | $314.5M |
| Interest on debt | $17.7M | $17.4M | $17.0M | $17.2M |
| Profit before tax | $269.2M | $329.1M | $209.7M | $289.4M |
| Tax | $51.7M | $43.3M | $40.2M | $56.5M |
| Net profit | $217.5M | $285.8M | $169.5M | $232.9M |
| EBITDA | $322.6M | $376.1M | $259.4M | $347.2M |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Mettler-Toledo International, I (MTD) Stock Forecasts
Leans bullishOct 23Zimmer Biomet Holdings, Inc. (ZBH) Stock forecasts
NeutralOct 22IDEXX Laboratories, Inc. (IDXX) Stock Forecasts
NeutralOct 22Zimmer Biomet Holdings, Inc. (ZBH) Stock forecasts
NeutralOct 22Will Mettler-Toledo (MTD) Beat Estimates Again in Its Next Earnings Report?
BullishOct 22FactSet Research Systems Inc. (FDS) Stock Forecasts
NeutralOct 22Mettler-Toledo stock hits 52-week high at 1660.31 USD By Investing.com
BullishOct 21Mettler-Toledo stock hits 52-week high at 1660.31 USD By Investing.com
BullishOct 21